Trichomonas vaginalis is an anaerobic, flagellated protozoan parasite and the most common curable STD. The World Health Organization (WHO) estimates that 170-190 million cases of infection are acquired annually worldwide and are increasing each year. As a result, T. vaginalis is receiving more attention, prompting an increased demand for both diagnosis of trichomoniasis and screening for asymptomatic infections.